Publications by authors named "Richard S Strauss"

Background: At diagnosis, up to one-third of patients with Crohn's disease (CD) have a complicated phenotype with stricturing (B2) or penetrating (B3) behavior or require early surgery. We evaluated protein biomarkers and antimicrobial antibodies in serum archived years before CD diagnosis to assess whether complicated diagnoses were associated with a specific serological signature.

Methods: Prediagnosis serum was obtained from 201 patients with CD and 201 healthy controls.

View Article and Find Full Text PDF

Background: Long-term safety, pharmacokinetics, and efficacy of open-label golimumab therapy in children with moderate-severe ulcerative colitis were evaluated.

Methods: Week-6 golimumab responders (Mayo score decrease of ≥30% and ≥3 points from baseline, rectal bleeding subscore of 0/1 or ≥1 decrease from baseline) entered the long-term extension at week 14 and received maintenance therapy (subcutaneous, q4w). Patients ≥45 kg could receive at-home treatments at week 18.

View Article and Find Full Text PDF

Population pharmacokinetics (PK) and exposure-response (E-R) analyses were conducted to compare the PK and E-R relationships of golimumab between children and adults with ulcerative colitis. PK data following subcutaneous golimumab administration to children with ulcerative colitis (6-17 years) in the PURSUIT-PEDS-PK study, adults with ulcerative colitis in the PURSUIT study, and children with pediatric polyarticular juvenile idiopathic arthritis (2-17 years) in the GO-KIDS study, were included in the population PK analysis. E-R analysis was conducted using logistic regression to link serum golimumab concentration and Mayo score-based efficacy outcomes in pediatric and adult ulcerative colitis.

View Article and Find Full Text PDF

Objective: Clinical response to topiramate can vary greatly in obese patients. Identifying genetic variants associated with treatment response could help gain insight into the mechanism of action of topiramate. Little is known about the relationship between genetic variability and topiramate treatment response.

View Article and Find Full Text PDF
Article Synopsis
  • Community-acquired pneumonia (CAP) can lead to hospitalization in 20% of cases, and ceftobiprole is a new antibiotic that targets major bacteria responsible for CAP, including resistant strains like MRSA.
  • A study involving 706 hospitalized CAP patients compared ceftobiprole against an expert-recommended treatment (ceftriaxone ± linezolid) and found similar cure rates, with 76.4% for ceftobiprole and 79.3% for the comparator.
  • Both treatments were well tolerated, but ceftobiprole had a slightly higher incidence of mild side effects like nausea and vomiting, yet it demonstrated non-inferiority, suggesting it could be a good option for treating
View Article and Find Full Text PDF

Ceftobiprole, a broad-spectrum cephalosporin with activity against methicillin (meticillin)-resistant staphylococci, was statistically noninferior to a combination of vancomycin plus ceftazidime in patients with complicated skin and skin structure infections (cSSSI). This analysis used data from this clinical trial to determine the relationship between therapeutic outcome and the percentage of time that the unbound ceftobiprole concentration exceeds the MIC (percent T>MIC). From the trial of ceftobiprole (500 mg every 8 h, 2-h infusion) for cSSSI due to gram-positive and/or gram-negative bacteria, data from 309 patients in the microbiological intent-to-treat analysis set with measured ceftobiprole concentrations and baseline MICs were used to assess the relationship between percent T>MIC and therapeutic outcome.

View Article and Find Full Text PDF

Background & Aims: Abdominal pain is common in adolescence. The aim of this study was to determine the prevalence of depressive symptoms in a large cohort of patients with frequent abdominal pain.

Methods: A prospective, cross-sectional, nationally representative sample of children aged 13 to 18 years (mean age, 16.

View Article and Find Full Text PDF
Article Synopsis
  • A randomized, double-blind trial compared the effectiveness of ceftobiprole monotherapy to a combination of vancomycin and ceftazidime in patients with complicated skin infections caused by gram-positive or gram-negative bacteria.
  • Results showed similar clinical cure rates for both treatment groups, with ceftobiprole achieving a 90.5% cure rate compared to 90.2% for the combination therapy in the clinically evaluable population.
  • The study concluded that ceftobiprole monotherapy is as effective as the combination therapy, with comparable rates of adverse events.
View Article and Find Full Text PDF
Article Synopsis
  • Ceftobiprole is a new cephalosporin antibiotic being tested against MRSA and was compared to vancomycin in a clinical trial for complicated skin infections.
  • The trial involved 784 patients, showing similar cure rates for both drugs (93.3% for ceftobiprole vs 93.5% for vancomycin) with effective results for MRSA cases specifically.
  • Adverse events were reported by around 52% of patients on ceftobiprole and 51% on vancomycin, with nausea and taste disturbance being the most common, but overall, ceftobiprole was deemed effective and well-tolerated.
View Article and Find Full Text PDF

As the prevalence of obesity and obesity-related disease among adolescents in the United States continues to increase, physicians are increasingly faced with the dilemma of determining the best treatment strategies for affected patients. This report offers an approach for the evaluation of adolescent patients' candidacy for bariatric surgery. In addition to anthropometric measurements and comorbidity assessments, a number of unique factors must be critically assessed among overweight youths.

View Article and Find Full Text PDF

Background: Overweight is the most common health problem that faces children and adolescents. Although the correlation among overweight, low self-esteem, and depression is well known, social isolation among overweight children and adolescents has not been studied.

Objective: To investigate social networks of overweight and normal-weight adolescents in a large, nationally representative sample.

View Article and Find Full Text PDF
Childhood obesity.

Pediatr Clin North Am

February 2002

The pediatrician's approach to overweight was best summarized by Bruch 25 years ago: The pediatrician plays an important role in the prevention of obesity. From birth on, feeding a child always involves a dual task--namely, offering food in appropriate amounts and gearing it to the child's expression of his needs. Only in this way can he develop discriminating awareness and become active in establishing self-regulation.

View Article and Find Full Text PDF